10-KPeriod: FY1997

BOSTON SCIENTIFIC CORP Annual Report, Year Ended Dec 31, 1997

Filed March 31, 1998For Securities:BSX

Summary

This 10-K filing for Boston Scientific Corp. (BSX) for the period ending December 30, 1997, filed on March 31, 1998, represents a snapshot of the company's financial health and strategic positioning at a crucial time in its growth. As an investor, understanding the context of this filing is vital, as it precedes significant developments and showcases the company's foundational strengths and potential for future expansion within the medical device industry. The filing details the company's operations, financial performance, and risk factors, providing a basis for evaluating its investment merit. Investors should pay close attention to the detailed financial statements and management's discussion and analysis to understand the company's revenue streams, profitability, and any identified challenges. This report serves as a critical document for assessing the company's trajectory and its ability to navigate the competitive landscape of medical technology.

Key Highlights

  • 1The filing pertains to the fiscal year ending December 30, 1997, submitted on March 31, 1998, providing historical financial data and company insights from that period.
  • 2Boston Scientific Corporation (BSX) is the subject of this 10-K report, indicating its status as a publicly traded company required to disclose annual financial information.
  • 3The filing includes detailed financial statements, management's discussion and analysis, and other critical disclosures necessary for investors to assess the company's performance and risks.
  • 4This report would contain information on BSX's product lines, market position, and growth strategies within the medical device sector as of 1997.
  • 5Investors can use this document to understand the company's financial health, revenue generation, and expenses during the reported fiscal year.
  • 6The filing serves as a foundational document for evaluating BSX's historical performance and making informed investment decisions, particularly for understanding its early-stage growth drivers.

Frequently Asked Questions

The primary purpose of this 10-K filing is to provide a comprehensive annual report on Boston Scientific Corp.'s financial performance, operations, and business conditions for the fiscal year ending December 30, 1997. It is a mandatory filing for publicly traded companies with the U.S. Securities and Exchange Commission (SEC) and serves to inform investors and the public about the company's financial health, strategies, and potential risks.

Investors can expect to find detailed audited financial statements, including balance sheets, income statements, and cash flow statements, covering the fiscal year 1997. Additionally, the filing typically includes Management's Discussion and Analysis (MD&A) of financial condition and results of operations, as well as information on the company's business segments, legal proceedings, and risk factors relevant to its operations.

While this filing is historical, it provides crucial context for understanding Boston Scientific's long-term trajectory, its growth path in the medical device industry, and the foundations upon which its current business was built. Investors can analyze its past performance, strategic decisions, and market positioning to better evaluate the company's evolution, its resilience, and the sustainability of its business model over the decades.

Based on Boston Scientific's known focus areas in the late 1990s, this 10-K would likely detail its operations in interventional cardiology, endoscopy, urology, and women's health, among other medical device specialties. The report would explain the performance and market dynamics of these segments, highlighting key products and growth drivers at that time.